step 11 semaglutide May Prove to Be an Effective Anti-Obesity Therapy Semaglutide in Patients with Obesity-Related

Weight loss injections do not directly interact with levothyroxine, but they slow gastric emptying and may cause gastrointestinal symptoms that could potentially affect thyroid medication absorption

Stress management matters because chronic stress elevates cortisol levels, which promotes fat storage particularly in the abdominal area

Cappellani D, Macchia E, Falorni A, Marchetti P

34 Given ovarian cancer is closely associated with obesity, hyperinsulinemia, and chronic inflammation, 35 it is also plausible that the metabolic improvements induced by GLP-1RAs contribute to reduced risk

Abdominal discomfort

Individual results vary based on dose, diet, exercise, and adherence